Current concepts in the non-operative management of rectal cancer after neoadjuvant chemoradiation

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1795-1800

  Singh Ranger, Gurpreet ^a   Kumar, Devinder ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Chemoradiation; Complete clinical response; Neoadjuvant therapy; Non operative management; Rectal cancer; Review

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FATALITY; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RECTUM CANCER; RECURRENT DISEASE; RESPONSE TIME; SHORT SURVEY; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 79958087843     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. Sterk P, Shekarriz B, Günter S, Nolde J, Keller R, Bruch HP and Shekarriz H: Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Colorectal Dis 20(5): 423-427, 2005. (Pubitemid 41086417)
2. Paun BC, Cassie S, MacLean AR, Dixon E and Buie WD: Postoperative complications following surgery for rectal cancer. Ann Surg 251(5): 807-818, 2010.
3. Onaitis MW, Noone RB, Fields R, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Seigler HF and Tyler DS: Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 8(10): 801-806, 2001. (Pubitemid 34003329)
4. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A and Ollier JC: EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11): 1114-1123, 2006. (Erratum in: N Engl J Med 357(7): 728, 2007.)
5. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A and Oates J: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24(4): 668-674, 2006. (Pubitemid 46630432)
6. Rutten H, Sebag-Montefiore D, Glynne-Jones R, Rullier E, Peeters M, Brown G, van Cutsem E, Ricci S, van de Velde C and Quirke P: Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: results of an international multicenter phase II study. Proc Am Soc Clin Oncol 24: 3528 (abstract), 2006.
7. Mohiuddin M, Winter K, Mitchell E, Hanna N, Yuen A, Nichols C, Shane R, Hayostek C and Willett C: Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer. Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24(4): 650-655, 2006. (Pubitemid 46630429)
8. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR and Gama-Rodrigues J: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4): 711-717; discussion, 717-718, 2004.
9. Nakagawa WT, Rossi BM, de O Ferreira F, Ferrigno R, David Filho WJ, Nishimoto IN, Vieira RA and Lopes A: Chemoradiation instead of surgery to treat mid and low rectal tumors: Is it safe? Ann Surg Oncol 9(6): 568-573, 2002.
10. Rossi BM, Nakagawa WT, Novaes PE, Filho WD and Lopes A: Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial. Ann Surg Oncol 5(2): 113-118, 1998. (Pubitemid 29071279)
11. Habr-Gama A, de Souza PM, Ribeiro U Jr, Nadalin W, Gansl R, Sousa AH Jr., Campos FG and Gama-Rodrigues J: Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41(9): 1087-1096, 1998. (Pubitemid 28432448)
12. Habr-Gama A, de Souza PM and Ribiero U: Multimodality therapy in low rectal cancer: long-term outcome of complete responders. Dis Colon Rectum 44: A18, 2001.
13. Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro U Jr., Silva E Sousa AH Jr., Campos FG, Kiss DR and Gama-Rodrigues J: Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 9(1): 90-9; discussion, 99-101, 2005.
14. AJCC Cancer Staging Handbook, Sixth Edition. Springer, 2004.
15. Skandarajah AR and Tjandra JJ: Preoperative locoregional imaging in rectal cancer. ANZ J Surg 76(6): 497-504, 2006. (Pubitemid 43846477)
16. Garcia-Aguilar J, Pollack J, Lee SH, Hernandez de Anda E, Mellgren A, Wong WD, Finne CO, Rothenberger DA and Madoff RD: Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 45(1): 10-15, 2002. (Pubitemid 34072746)
17. Manisch F, Koch A, Schmidt U, Zippel R, Kuhn R, Wolff S, Pross M, Wierth A, Gastinger I and Lippert H: Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 34(5): 385-390, 2002. (Pubitemid 34464198)
18. Thaler W, Watzka S, Martin F, La Guardia G, Psenner K, Bonatti G, Fichtel G, Egarter-Vigl E and Marzoli GP: Preoperative staging of rectal cancer by endoluminal ultrasound vs. magnetic resonance imaging. Preliminary results of a prospective, comparative study. Dis Colon Rectum 37(12): 1189-1193, 1994.
19. Hildebrandt U, Klein T, Feifel G, Schwarz HP, Koch B and Schmitt RM: Endosonography of pararectal lymph nodes. In vitro and in vivo evaluation. Dis Colon Rectum 33(10): 863-868, 1990.
20. Tio TL, Coene PP, van Delden OM and Tytgat GN: Colorectal carcinoma: preoperative TNM classification with endosonography. Radiology 179(1): 165-170, 1991.
21. Thoeni RF, Moss AA, Schnyder P and Margulis AR: Detection and staging of primary rectal and rectosigmoid cancer by computed tomography. Radiology 141(1): 135-138, 1981. (Pubitemid 11006925)
22. Grabbe E, Lierse W and Winkler R: The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology 149(1): 241-246, 1983. (Pubitemid 13006840)
23. van Waes PF, Koehler PR and Feldberg MA: Management of rectal carcinoma: impact of computed tomography. AJR Am J Roentgenol 140(6): 1137-1142, 1983. (Pubitemid 13054769)
24. Koehler PR, Feldberg MA and van Waes PF: Preoperative staging of rectal cancer with computerized tomography. Accuracy, efficacy, and effect on patient management. Cancer. 54(3): 512-516, 1984.
25. Rifkin MD, Ehrlich SM and Marks G: Staging of rectal carcinoma: prospective comparison of endorectal US and CT. Radiology 170(2): 319-322, 1989. (Pubitemid 19035646)
26. Guinet C, Buy JN, Ghossain MA, Sézeur A, Mallet A, Bigot JM, Vadrot D and Ecoiffier J: Comparison of magnetic resonance imaging and computed tomography in the preoperative staging of rectal cancer. Arch Surg 125(3): 385-388, 1990. (Pubitemid 20079084)
27. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P and Gerard JP: Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17(8): 2396, 1999.
28. Tulchinsky H, Shmueli E, Figer A, Klausner JM and Rabau M: An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15(10): 2661-2667, 2008.
29. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J and Cecconello I: Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71(4): 1181-1188, 2008.
30. Cammà C, Giunta M, Fiorica, F, Pagliaro L, Craxì A and Cottone M: Preoperative radiotherapy for resectable rectal cancer; a meta-analysis. JAMA 284: 1008-1015, 2000. (Pubitemid 30659131)
31. Van den Brink M, Stiggelboult AM, van den Hout WB, Kievit J, Klein Kranenberg E, Marjinen CA, Nagtegaal ID, Rutten HJ, Wiggers T and van de Viede CJ: Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 22(19): 3958-3964, 2004. (Pubitemid 41079878)
32. Frykholm GJ, Pahlman L and Glimelius B: Treatment of local recurrences of rectal carcinoma. Radiother Oncol 34: 185-194, 1995.
33. Holm T, Cedermark B and Rutqvist LE: Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg 81: 452-455, 1994.
34. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS, Dinwoodie W, Karl RC and Marcet J: Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234(3): 352-358; discussion, 358-359, 2001.
35. Borschitz T, Wachtlin D, Möhler M, Schmidberger H and Junginger T: Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15(3): 712-720, 2008.
36. Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR and Gama-Rodrigues JJ: Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis 20(5): 434-439, 2005. (Pubitemid 41086419)
37. Zmora O, Dasilva GM, Gurland B, Pfeffer R, Koller M, Nogueras JJ and Wexner SD: Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum 47(10): 1607-1612, 2004.
38. O'Neill BD, Brown G, Heald RJ, Cunningham D and Tait DM: Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 8(7): 625-633, 2007. (Pubitemid 47008889)